DC1 native/mutated ESR1(H Lee Moffitt Cancer Center & Research Institute)

N/A

Report date: 2024/12/13 20:00:39

Base Information

Drug NameDC1 native/mutated ESR1(H Lee Moffitt Cancer Center & Research Institute)

Drug Alias NameN/A

ClassificationVaccines > Development/production technology > Dendritic cell vaccineCell and gene therapy > Cell therapy > Immune system cell therapy > Dendritic cell therapy > Dendritic cell vaccineVaccines > Application > Therapeutic vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsMetastatic breast cancerBreast Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaN/A

Originator CompaniesH Lee Moffitt Cancer Center & Research Institute

China Registration ClassN/A

Develop Information

Active CompaniesH Lee Moffitt Cancer Center & Research Institute

Inactive CompaniesN/A

Active IndicationsMetastatic breast cancerBreast Neoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A